breakthrough

Bozo.Finance. A Groundbreaking NFTxTOKEN Solution Revolutionizing Decentralized Finance.

  Bozo.Finance / Bozo Hybrid In an innovative leap forward for the DeFi space, Bozo Hybrid announces the launch of its revolutionary platform - a first-of-its-kind NFTxTOKEN hybrid that is reshaping the landscape of liquidity and asset interchangeability. The Game-Changing Innovation of Bozo HYBRID Bozo HYBRID is not just another project in the blockchain space. It represents a paradigm shift, a true DeFi 2.0 model, by integrating non-fungible tokens (NFTs) with fungible tokens ($bozo tokens) to create a two-way liquidity portal. This hybrid approach is a breakthrough in the market,

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Erez Capital Makes Investment in Curio® Converting Nuclear Waste into Sustainable Energy

Boston, August 24, 2023 - Erez Capital, a rising star in the venture capital arena with a firm focus on disruptive technologies, is thrilled to announce a strategic investment of $100,000 in Curio®, an avant-garde deeptech startup. Curio stands at the vanguard of nuclear technology innovation, pioneering the develop and commercialization cutting-edge technologies that are aimed at converting nuclear waste into safe and sustainable energy sources. "Throughout Erez Capital's journey, I've had the privilege of engaging with numerous startups. Among them, Curio shines as a company positioned to reshape the

Blockchain Life will host the 10th Global Blockchain and Crypto Forum in Dubai

DUBAI, Feb 13, 2023 - (ACN Newswire) - The 10th Global Forum on blockchain, cryptocurrencies and mining -- Blockchain Life 2023 takes place on February 27-28 in Dubai. The event is attended by key industry players, government representatives, heads of international companies and funds, investors, promising startups teams and beginners. It's noteworthy that the Forum is a meeting point for a premium crypto audience including world Crypto Whales. What to expect? Whales of the crypto industry at one place Top speakers with world-changing insights and analytics Global expo of the

Somnium Space Fashion Show with TESLASUIT

In association with TESLASUIT, the human-to-digital interface, Metaverse platform Somnium Space is organising the first virtual reality avatar fashion week in history - held in Prague and in the virtual world this September. Somnium Space Fashion Week (September 7-11) is an event enabling designers and brands to connect with consumers in an entirely new way, making it a one of a kind phygital experience. It will expand the way fashion is presented to the public, allowing people to connect from around the globe in one physical and digital location simultaneously

6th Annual ConV2X Telehealth 2022 Event Announced

The acclaimed annual telehealth event catalyzes C-suite global market executives driving the transformation of telehealth, data science, and edge technologies and includes healthcare leadership & breakthrough technology providers to inspire and guide informed decision making to successfully navigate a new digital health era. The full day event will present keynotes, panel discussions, and unparalleled business and research network opportunities The audience includes top multidisciplinary global leaders from platform providers, health systems, payors, universities, government, NGO, consultants, think tanks, clinicians, pharmaceutical & medical device manufacturers, VCs/Investors, students and startups. Date: Thursday,